A

Aceso Life Science Group Ltd
HKEX:474

Watchlist Manager
Aceso Life Science Group Ltd
HKEX:474
Watchlist
Price: 0.118 HKD 0.85% Market Closed
Market Cap: HK$1B

Balance Sheet

Balance Sheet Decomposition
Aceso Life Science Group Ltd

Balance Sheet
Aceso Life Science Group Ltd

Rotate your device to view
Balance Sheet
Currency: HKD
Mar-2003 Mar-2004 Mar-2005 Mar-2006 Mar-2007 Mar-2008 Mar-2009 Mar-2010 Mar-2011 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
48
57
58
55
65
76
55
303
49
44
283
416
204
296
849
781
267
382
214
291
741
Cash
48
57
58
55
65
76
55
303
49
44
283
416
204
296
849
781
267
382
16
96
554
Cash Equivalents
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
198
195
187
Short-Term Investments
21
30
41
50
46
30
13
0
0
0
0
0
2 957
4 860
1 241
1 258
1 404
199
588
522
415
Total Receivables
16
14
22
29
30
45
32
21
35
41
287
524
821
866
946
760
902
914
756
1 065
757
Accounts Receivables
12
10
17
18
16
26
16
9
20
23
13
10
8
0
80
123
99
61
135
149
115
Other Receivables
5
5
5
12
14
20
16
12
15
18
274
514
813
866
866
636
803
853
621
916
642
Inventory
20
17
26
24
33
33
29
21
27
26
19
3
1
0
9
23
6
89
458
374
354
Other Current Assets
0
0
0
0
0
0
0
56
1
2 493
1 632
45
46
634
45
60
76
50
26
110
30
Total Current Assets
105
118
147
159
174
184
129
401
112
2 604
2 221
988
4 028
6 656
3 089
2 883
2 655
1 634
2 026
2 266
2 297
PP&E Net
12
11
13
16
16
18
15
70
264
49
86
74
84
83
569
541
450
411
291
283
281
PP&E Gross
12
11
13
16
16
18
15
70
264
49
86
74
84
83
569
541
450
411
291
283
0
Accumulated Depreciation
16
17
18
20
22
22
23
27
32
31
31
11
16
19
31
97
161
181
259
315
0
Intangible Assets
0
0
0
0
0
0
0
1 903
1 989
1 552
0
0
0
0
179
179
175
173
156
158
171
Goodwill
0
0
10
10
11
13
11
0
0
0
0
0
0
0
415
99
99
13
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
34
7
56
0
127
205
122
236
94
28
47
Long-Term Investments
12
17
11
11
13
33
35
23
14
12
196
1 061
1 288
1 424
793
952
1 982
2 503
3 524
3 454
3 451
Other Long-Term Assets
8
7
5
5
4
4
9
106
367
98
151
701
736
147
171
171
72
63
74
74
54
Other Assets
0
0
10
10
11
13
11
0
0
0
0
0
0
0
415
99
99
13
0
0
0
Total Assets
137
N/A
153
+12%
185
+21%
200
+8%
218
+9%
252
+16%
198
-21%
2 502
+1 164%
2 745
+10%
4 315
+57%
2 689
-38%
2 830
+5%
6 193
+119%
8 428
+36%
5 343
-37%
5 030
-6%
5 555
+10%
5 033
-9%
6 165
+22%
6 263
+2%
6 301
+1%
Liabilities
Accounts Payable
9
6
11
11
10
15
7
6
15
11
8
25
0
0
61
77
15
37
4
6
13
Short-Term Debt
0
0
1
1
0
5
0
9
0
0
123
0
0
203
150
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
638
0
210
573
464
747
767
627
770
794
2 136
2 151
Other Current Liabilities
6
16
13
23
19
24
13
151
34
922
110
28
551
630
383
411
250
242
298
309
691
Total Current Liabilities
14
22
25
35
29
43
20
166
49
1 571
241
262
1 123
1 297
1 342
1 255
892
1 049
1 096
2 451
2 855
Long-Term Debt
0
0
1
0
0
0
0
369
218
0
0
14
145
165
199
605
1 814
1 426
1 337
245
193
Deferred Income Tax
0
0
0
0
0
0
0
475
496
0
0
0
0
0
134
106
65
62
90
111
100
Minority Interest
0
0
0
0
0
0
0
0
0
0
5
5
0
208
237
272
153
6
632
825
1 026
Other Liabilities
0
0
1
1
1
1
1
394
182
9
1
0
0
99
106
0
0
0
628
629
578
Total Liabilities
15
N/A
22
+49%
27
+23%
36
+34%
30
-17%
44
+50%
21
-53%
1 404
+6 617%
945
-33%
1 580
+67%
247
-84%
281
+14%
1 268
+351%
1 768
+39%
2 019
+14%
2 238
+11%
2 924
+31%
2 543
-13%
3 783
+49%
4 261
+13%
4 752
+12%
Equity
Common Stock
0
0
0
0
20
20
21
84
121
333
197
199
29
36
42
49
53
61
69
74
73
Retained Earnings
120
128
148
155
162
175
141
336
416
602
668
680
1 030
1 855
1 616
2 029
1 563
1 845
2 245
2 730
1 476
Additional Paid In Capital
0
0
7
7
0
3
5
1 337
2 008
2 819
2 820
2 824
3 302
3 647
4 276
4 273
4 353
4 531
4 727
4 811
0
Unrealized Security Profit/Loss
0
0
0
0
0
4
2
3
1
2
17
204
562
0
631
489
218
233
231
184
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
0
Other Equity
2
4
4
3
6
14
9
10
86
182
77
2
2
1
9
9
6
24
62
36
0
Total Equity
122
N/A
132
+7%
159
+21%
165
+4%
188
+14%
207
+10%
177
-15%
1 098
+520%
1 800
+64%
2 735
+52%
2 442
-11%
2 549
+4%
4 925
+93%
6 660
+35%
3 324
-50%
2 792
-16%
2 631
-6%
2 490
-5%
2 382
-4%
2 002
-16%
1 549
-23%
Total Liabilities & Equity
137
N/A
153
+12%
185
+21%
200
+8%
218
+9%
252
+16%
198
-21%
2 502
+1 164%
2 745
+10%
4 315
+57%
2 689
-38%
2 830
+5%
6 193
+119%
8 428
+36%
5 343
-37%
5 030
-6%
5 555
+10%
5 033
-9%
6 165
+22%
6 263
+2%
6 301
+1%
Shares Outstanding
Common Shares Outstanding
246
246
246
246
214
217
220
901
1 289
2 099
2 100
2 122
3 779
4 249
4 884
4 898
5 285
6 092
6 932
7 327
7 382
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett